A test kit with a reader-enabled direct antigen testing in suspected COVID-19 samples. It is based on the technology called Localized Surface Plasmon Resonance Enhancement which enables quantifiable measurement of proteins at less than 100pg concentrations. The technology is a rapid alternate to RT-PCR and can be deployed at Point-of-Care locations.
Accessibility Controls